|
SNAPC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.76930000000053E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.295320E-03 |
| Normal-vs-Stage2 |
4.21230000000605E-05 |
| Normal-vs-Stage3 |
2.09559999999609E-05 |
| Normal-vs-Stage4 |
1.67965999999797E-05 |
| Stage1-vs-Stage2 |
1.068370E-01 |
| Stage1-vs-Stage3 |
2.518400E-01 |
| Stage1-vs-Stage4 |
6.875900E-02 |
| Stage2-vs-Stage3 |
4.880000E-01 |
| Stage2-vs-Stage4 |
9.764800E-01 |
| Stage3-vs-Stage4 |
4.451200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.582440E-04 |
| Normal-vs-AfricanAmerican |
9.676800E-03 |
| Normal-vs-Asian |
1.631510E-04 |
| Caucasian-vs-AfricanAmerican |
9.481400E-01 |
| Caucasian-vs-Asian |
4.406000E-01 |
| AfricanAmerican-vs-Asian |
5.101800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.423100E-04 |
| Normal-vs-Female |
1.92015999999073E-05 |
| Male-vs-Female |
7.809000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.323610E-03 |
| Normal-vs-Age(41-60Yrs) |
2.3561999999977E-05 |
| Normal-vs-Age(61-80Yrs) |
5.18809999960901E-07 |
| Normal-vs-Age(81-100Yrs) |
2.350300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.245200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.443800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.366400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.102600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.910800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.701400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.270410E-02 |
| Classical-VS-Follicular |
5.688400E-01 |
| Classical-VS-Other |
8.208400E-01 |
| Classical-VS-Normal |
1.026800E-04 |
| Tall-VS-Follicular |
2.768000E-02 |
| Tall-VS-Other |
3.995000E-01 |
| Tall-VS-Normal |
1.12860000001103E-06 |
| Follicular-VS-Other |
7.302000E-01 |
| Follicular-VS-Normal |
1.374020E-02 |
| Other-VS-Normal |
8.907900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.64420000000099E-05 |
| Normal-vs-N1 |
8.20820000000388E-05 |
| N0-vs-N1 |
5.692400E-01 |
|
|
